Efficacy of Antiretroviral Drugs Against Equine Infectious Anemia Virus
Author Information
Author(s): Cécile Schimmich, Astrid Vabret, José-Carlos Valle-Casuso
Primary Institution: ANSES Animal Health Laboratory, France
Hypothesis
This study evaluates the in vitro antiviral effect of eighteen FDA-approved antiretroviral compounds against equine infectious anemia virus (EIAV).
Conclusion
Thirteen out of eighteen tested antiretroviral drugs showed significant antiviral effects against EIAV in vitro.
Supporting Evidence
- Thirteen compounds were identified as effective against EIAV in vitro.
- Tested NRTIs, PIs, and INSTIs have an antiviral effect against EIAV in equine cells.
- NNRTIs, FI, and CI showed no antiviral effect against EIAV.
Takeaway
Scientists tested 18 medicines that help fight HIV to see if they could also help horses with a virus called EIAV, and found that 13 of them worked well.
Methodology
The study involved treating equine cells with FDA-approved antiretroviral drugs and measuring the viral RNA and DNA levels after infection with EIAV.
Limitations
The study was conducted in vitro, and results may not directly translate to in vivo efficacy.
Participant Demographics
Equine cells from healthy EIAV-negative horses were used in the study.
Statistical Information
P-Value
p.adj<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website